Guinea to start final trials of Ebola vaccines this weekIf the World Health Organization is successful in the coming days the Ebola virus may be prevented from spreading like wildfire again! That’s because, according to reports the (WHO) says the first large-scale trial of an Ebola vaccine will begin in the African nation of Guinea, weeks after a similar test had been carried out in neighboring Liberia. The candidate vaccine, VSV-EBOV, will undergo Phase III testing in the areas of Basse Guinee, the region that currently has the highest number of cases in Guinea, on March 7, WHO confirmed on Thursday. “If a vaccine is found (to be) effective, it will be the first preventive tool against Ebola in history,” WHO Director General Margaret Chan said. VSV-EBOV along with CAd3 are two candidate vaccines in the most advanced stages of development and have already passed safety tests on humans. FULL REPORT